Dasatrue Dasatinib – 50 mg, 70 mg Tablets

Buy Dasatrue Dasatinib Tablets 50 mg / 70 mg Online

Dasatrue Dasatinib Tablets 50 mg / 70 mg (1 pack / 60 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Dasatrue

Strength & Pack Size: 50 mg or 70 mg per tablet; 1 pack / 60 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Tyrosine kinase inhibitor (TKI), BCR-ABL inhibitor (targeted anticancer therapy)

Primary Indication: Chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) where dasatinib is appropriate

Typical Use in Therapy: Used within a hematology–oncology plan with response monitoring and blood tests

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed; protect from moisture and keep out of reach of children

Product Description

Dasatrue contains dasatinib, a targeted oral tyrosine kinase inhibitor used in CML and Ph+ ALL when a qualified hematology–oncology specialist determines it is appropriate. Dasatrue is supplied as dasatinib tablets in two strengths (50 mg and 70 mg), with this listing covering 1 pack / 60 tablets per selected strength. If you plan to buy Dasatrue online, match the strength to your prescription and monitoring plan rather than choosing based only on price or availability.

In Philadelphia chromosome–positive leukemias, the abnormal BCR-ABL signal is a key driver of malignant cell growth. Dasatinib targets this pathway as a second-generation TKI, and treatment decisions are individualized based on disease phase, prior therapies, response goals, tolerability, and interaction risks. Patients are usually followed with scheduled blood counts and response assessments, and dose changes are made only by the treating team. Dasatrue is prescription-only and should not be started, stopped, or adjusted without specialist supervision.

Generic Meds Mart supplies Dasatrue dasatinib tablets in original manufacturer packaging sourced through licensed channels. Packs typically show the product name, selected strength, active ingredient, batch number, and expiry date to support pharmacy verification on receipt. Orders are shipped in discreet outer packaging, and delivery wording is kept practical (global delivery / international delivery / worldwide delivery) so patients and clinics can coordinate refills with planned monitoring.

Key Uses

Dasatrue (dasatinib) is used for CML and Ph+ ALL when BCR-ABL tyrosine kinase inhibition is clinically appropriate. These conditions require specialist-led monitoring because both efficacy and safety depend on individualized dosing, response checks, and early recognition of complications such as cytopenias or fluid-related effects. Your hematology team defines the treatment goals, what response milestones are expected, and what follow-up schedule is required.

Common Searches and Treatment Contexts for Dasatinib

• Generic Sprycel (Dasatinib): Dasatrue is a therapeutically equivalent generic version of the brand-name drug Sprycel, containing the same active ingredient (dasatinib 50 mg or dasatinib 70 mg) for the treatment of CML and Ph+ ALL.
• BCR-ABL TKI for CML: Dasatinib is a potent second-generation tyrosine kinase inhibitor that targets the BCR-ABL protein, a key driver in Philadelphia chromosome–positive leukemias.
• Dasatinib 50 mg Tablets / Dasatinib 70 mg Tablets: These strengths are used within individualized regimens prescribed by a hematology specialist based on response and tolerability.
• Buy Dasatinib Online: Patients with a confirmed prescription and monitoring plan may seek reliable access to original-packaging dasatinib to maintain therapy continuity.

How Dasatinib Works in Chemotherapy

Dasatinib inhibits tyrosine kinases involved in leukemia cell signaling, including BCR-ABL. In Ph+ disease, BCR-ABL signaling promotes uncontrolled growth and survival of malignant cells. By blocking these signals, dasatinib reduces downstream pathways that cancer cells rely on, supporting disease control when taken consistently as prescribed within a specialist-managed plan.

Because dasatinib is targeted therapy rather than classic cytotoxic chemotherapy, the side-effect profile differs, but monitoring remains essential. Your specialist may monitor blood counts, infection signs, bleeding risk, and symptoms suggestive of fluid accumulation. Treatment decisions should always be made with your hematology team, especially if you take other medicines that may interact.

Dosage & Administration

Dasatrue tablets must be taken exactly as prescribed by your hematology–oncology specialist. Dasatinib dosage is individualized and may be adjusted based on disease phase, treatment response, tolerability, and interacting medicines. Swallow tablets whole with water and follow the schedule provided by your clinic. If you miss a dose, follow your clinic’s instructions rather than taking extra tablets to compensate.

Interactions can be clinically important with dasatinib. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your specialist and pharmacist before starting therapy and before adding anything new. Never stop or change dosing without medical advice, because continuity and monitoring are core parts of safe targeted treatment.

Precautions

Dasatinib can affect blood counts, increasing infection and bleeding risk. Seek medical advice urgently for fever, chills, unusual bruising, prolonged bleeding, black stools, or severe fatigue. Fluid-related effects such as pleural effusion may occur in some patients and can present as cough, chest discomfort, or shortness of breath; new or worsening breathing symptoms should be assessed promptly.

Your specialist will also consider other risk factors and may recommend specific monitoring based on your situation. Pregnancy should be avoided during anticancer therapy, and contraception planning should be discussed with a qualified healthcare professional.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects may include diarrhea, nausea, fatigue, headache, muscle or joint aches, mild rash, and laboratory changes in blood counts. Many effects can be managed within a specialist-led plan, but persistent or worsening symptoms should be discussed with your care team rather than managed by changing the dose independently.

Serious side effects

Serious side effects require urgent medical attention and may include major bleeding, severe or recurrent infections, significant reductions in blood counts, or clinically important fluid accumulation around the lungs. If you develop high fever, heavy bleeding, black stools, chest pain, fainting, or rapidly worsening shortness of breath, seek urgent care and tell clinicians you are taking dasatinib.

Storage

Store Dasatrue in the original packaging as directed on the label, protect from moisture and excessive heat, and keep out of reach of children. Do not use after the expiry date on the carton or blister/bottle. Follow any clinic-specific handling instructions provided for oncology medicines.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty medicines such as Dasatrue dasatinib tablets. Products are supplied in original packaging from licensed channels with batch and expiry information for verification. Pricing is displayed in USD, checkout is secure, and shipments are packed in discreet outer cartons to protect privacy.

For patients managing CML or Ph+ ALL within a monitoring plan, reliable access can support therapy continuity. Global delivery options and tracking can help align refills with blood tests and specialist visits. Generic Meds Mart does not replace your treating doctor, and all clinical decisions about dasatinib therapy, including monitoring and side-effect management, must be made by qualified healthcare professionals.

Order Now

Before you order Dasatrue, you should have a confirmed diagnosis of CML or Ph+ ALL and a treatment plan agreed with your hematology–oncology specialist. Your care team will explain which monitoring tests are required and how often, and they will review interaction risks with your current medicines. Once your plan is confirmed, select the correct strength (Dasatrue 50 mg or Dasatrue 70 mg), add 1 pack / 60 tablets to your cart, and complete checkout in USD.

Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop concerning symptoms such as heavy bleeding, high fever, chest pain, or worsening shortness of breath, seek urgent medical care and inform clinicians that you are taking dasatinib.

FAQ about Dasatrue (Dasatinib)

Q1: What is Dasatrue used for?
Dasatrue contains dasatinib, a targeted tyrosine kinase inhibitor used in CML and Ph+ ALL when prescribed by a hematology–oncology specialist as part of a complete treatment plan.

Q2: Is Dasatrue a chemotherapy medicine or targeted therapy?
Dasatrue (dasatinib) is targeted therapy that inhibits BCR-ABL and related kinases in Philadelphia chromosome–positive disease. It still requires specialist supervision and monitoring.

Q3: How should I take Dasatrue tablets?
Take Dasatrue exactly as prescribed. Swallow tablets whole with water and follow your specialist’s schedule and monitoring instructions.

Q4: What should I know about dasatinib dosage and missed doses?
Dasatinib dosage is individualized by your specialist. If you miss a dose, follow your clinic’s instructions and do not take extra tablets unless your specialist tells you to.

Q5: What are common dasatinib side effects to monitor?
Common dasatinib side effects can include diarrhea, fatigue, rash, and changes in blood counts. Report persistent or severe symptoms so your care team can advise safely.

Q6: Is Dasatrue 50 mg or 70 mg the same as Sprycel (Generic Sprycel)?
Dasatrue is Generic Sprycel — it contains the same active ingredient (dasatinib) as Sprycel. It’s used for the same indication at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.